Stay updated on GEMINI 2 Tolebrutinib in RMS Clinical Trial

Sign up to get notified when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GEMINI 2 Tolebrutinib in RMS Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.0%
    Check dated 2025-06-13T16:10:04.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page has been updated to reflect the submission of results, and the revision number has changed from v2.16.1 to v2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T09:38:51.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.
    Difference
    0.8%
    Check dated 2025-05-30T04:38:13.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-23T01:55:57.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T05:56:29.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page has removed detailed information about the objectives, inclusion and exclusion criteria, and study design for a clinical trial on SAR442168 for relapsing forms of multiple sclerosis, while adding a new registry identifier and a version revision number.
    Difference
    22%
    Check dated 2025-04-16T15:03:43.000Z thumbnail image

Stay in the know with updates to GEMINI 2 Tolebrutinib in RMS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.